Gene Therapy

Key Buffer Considerations for AAV Full Capsid Enrichment

November 02, 2022

Process Intensification in AAV Gene Therapy

November 14, 2022
Blogs

FDA Approves World’s Most Expensive Gene Therapy for Rare Disease + CDC Concerned About New COVID-19 Variant – Xtalks Life Science Podcast Ep. 79
Approvals News

Bluebird Bio’s Skysona Receives FDA Approval and Becomes World’s Most Expensive Drug
Blogs

FDA Approval of First Rapid-Acting Oral Depression Drug + Approval of $2.8 Million Gene Therapy for Rare Blood Disorder – Xtalks Life Science Podcast Ep. 75
Approvals News

Roctavian, the First Hemophilia A Gene Therapy, Attains EC Approval
Approvals News

Bluebird’s $2.8M Gene Therapy Zynteglo Wins Landmark FDA Approval for Beta Thalassemia

Examining the Use of Osmolality within Viral Vector Manufacturing

June 28, 2022

Changing Times, Changing Therapies: Keeping Up with Advancements in Cell and Gene Therapies

May 25, 2022
Blogs

UK’s NHS Backs World’s Costliest Drug for Treatment of MLD + Report Finds Increase in Pharma Cybersecurity Threats – Xtalks Life Science Podcast Ep. 48
Approvals News

UK’s NHS Backs World’s Costliest Drug Libmeldy for the Treatment of Rare Disease MLD
Biotech News

The Israeli Society of Gene and Cell Therapy 2022 Meeting Will Bring Researchers Together

Total Antibody Assays for AAV-Based Gene Therapies – To Bridge or Not to Bridge

December 06, 2021

Planning the Global Supply Chain Journey for Cell and Gene Therapy Companies

November 09, 2021

The Role of Adaptive Logistics and Patient Focus in ATMP Clinical Trial Success

October 22, 2021
Biotech News

BioMarin Gene Therapy Halted by FDA Over Safety Concerns